- Home
- NCZ vs MIR Comparison
NCZ vs MIR Comparison
Compare NCZ & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCZ
- MIR
- Stock Information
- Founded
- NCZ 2003
- MIR 2005
- Country
- NCZ United States
- MIR United States
- Employees
- NCZ N/A
- MIR N/A
- Industry
- NCZ Finance Companies
- MIR Industrial Machinery/Components
- Sector
- NCZ Finance
- MIR Technology
- Exchange
- NCZ Nasdaq
- MIR Nasdaq
- Market Cap
- NCZ 228.3M
- MIR 5.0B
- IPO Year
- NCZ N/A
- MIR N/A
- Fundamental
- Price
- NCZ $12.74
- MIR $20.78
- Analyst Decision
- NCZ
- MIR Strong Buy
- Analyst Count
- NCZ 0
- MIR 4
- Target Price
- NCZ N/A
- MIR $21.00
- AVG Volume (30 Days)
- NCZ 533.0K
- MIR 3.4M
- Earning Date
- NCZ 01-01-0001
- MIR 07-31-2025
- Dividend Yield
- NCZ 12.16%
- MIR N/A
- EPS Growth
- NCZ N/A
- MIR N/A
- EPS
- NCZ N/A
- MIR N/A
- Revenue
- NCZ N/A
- MIR $870,200,000.00
- Revenue This Year
- NCZ N/A
- MIR $6.73
- Revenue Next Year
- NCZ N/A
- MIR $7.58
- P/E Ratio
- NCZ N/A
- MIR N/A
- Revenue Growth
- NCZ N/A
- MIR 7.25
- 52 Week Low
- NCZ $2.50
- MIR $9.11
- 52 Week High
- NCZ $3.15
- MIR $22.21
- Technical
- Relative Strength Index (RSI)
- NCZ 75.05
- MIR 55.14
- Support Level
- NCZ $12.78
- MIR $20.14
- Resistance Level
- NCZ $12.95
- MIR $20.96
- Average True Range (ATR)
- NCZ 0.14
- MIR 0.74
- MACD
- NCZ 0.02
- MIR -0.16
- Stochastic Oscillator
- NCZ 97.56
- MIR 43.64
About NCZ Virtus Convertible & Income Fund II of Beneficial Interest
Virtus Convertible & Income Fund II is a diversified, closed-end management investment company. The investment objective of the company is to provide total return through a combination of capital appreciation and high current income. Its portfolio of investments includes different sector investments such as in healthcare services, media, oil, gas, and consumable fuels and others.
About MIR Mirion Technologies Inc.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.